Ftse Mib
35.390,52
-0,06%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.923,39
2,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Bio Rad Laboratories Inc (BIO) Bio Rad Laboratories Inc (BIO) Notizie

BIO

Bio Rad Laboratories (BIO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:BIO
DataOraFonteTitoloSimboloCompagnia
09/05/202422:30Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:BIOBio Rad Laboratories Inc
08/05/202422:38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BIOBio Rad Laboratories Inc
08/05/202422:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIOBio Rad Laboratories Inc
08/05/202420:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:BIOBio Rad Laboratories Inc
07/05/202422:18Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIOBio Rad Laboratories Inc
07/05/202422:15Business WireBio-Rad Reports First-Quarter 2024 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
01/05/202415:00Business WireBio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
26/04/202414:30Business WireBio-Rad Announces Life Science Group Management ChangesNYSE:BIOBio Rad Laboratories Inc
18/04/202415:00Business WireBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NYSE:BIOBio Rad Laboratories Inc
11/04/202423:30GlobeNewswire Inc.Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayNYSE:BIOBio Rad Laboratories Inc
10/04/202422:15Business WireBio-Rad’s Chief Operating Officer Andrew Last to RetireNYSE:BIOBio Rad Laboratories Inc
20/03/202413:30Business WireBio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial OfficerNYSE:BIOBio Rad Laboratories Inc
22/02/202422:30Business WireBio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access DayNYSE:BIOBio Rad Laboratories Inc
15/02/202422:15Business WireBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
24/01/202423:00Business WireBio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024NYSE:BIOBio Rad Laboratories Inc
02/01/202422:15Business WireBio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
26/10/202322:15Business WireBio-Rad Reports Third-Quarter 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
05/10/202314:30Business WireBio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023NYSE:BIOBio Rad Laboratories Inc
28/08/202322:15Business WireBio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
03/08/202322:15Business WireBio-Rad Reports Second-Quarter 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
26/07/202322:15Business WireBio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing AgreementNYSE:BIOBio Rad Laboratories Inc
20/07/202322:30Business WireBio-Rad Announces New Share Repurchase ProgramNYSE:BIOBio Rad Laboratories Inc
10/07/202322:30Business WireBio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023NYSE:BIOBio Rad Laboratories Inc
10/07/202315:00Business WireBio-Rad Publishes Corporate Sustainability Report for 2022NYSE:BIOBio Rad Laboratories Inc
15/06/202323:13Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:BIOBio Rad Laboratories Inc
07/06/202317:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:BIOBio Rad Laboratories Inc
05/06/202314:46Edgar (US Regulatory)Current Report Filing (8-k)NYSE:BIOBio Rad Laboratories Inc
01/06/202314:00Business WireBio-Rad to Present Company Overview at Jefferies Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
24/05/202322:51Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:BIOBio Rad Laboratories Inc
08/05/202314:00Business WireBio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:BIO

La tua Cronologia

EU
I3VOD
LS 3VOD INAV
COIN
KB3ETH
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network